Wright Medical Group N.V. (WMGI)
(Delayed Data from NSDQ)
$29.93 USD
+0.29 (0.98%)
Updated May 3, 2019 04:00 PM ET
After-Market: $29.93 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$29.93 USD
+0.29 (0.98%)
Updated May 3, 2019 04:00 PM ET
After-Market: $29.93 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Wright Medical Buys Cartiva to Boost Lower Extremities Unit
by Zacks Equity Research
Wright Medical's (WMGI) addition of Synthetic Cartilage Implant is likely to drive revenues in 2019; raised guidance for 2018 encourages.
Wright Medical Strong Overseas, Back Order Issues Persist
by Zacks Equity Research
Wright Medical (WMGI) rides on recent approval of AUGMENT Injectable and a solid guidance for 2018; pricing pressure prevails.
Wright Medical (WMGI) Beats on Q2 Earnings, Raises '18 View
by Zacks Equity Research
Growth in the upper and lower extremity segments drives Wright Medical's (WMGI) Q2 results.
Wright Medical Group (WMGI) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Wright Medical (WMGI) delivered earnings and revenue surprises of 50.00% and 4.20%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Abiomed (ABMD) Lags Q1 Earnings Estimates, Raises '19 View
by Zacks Equity Research
Abiomed's (ABMD) flagship Impella line continues to drive growth in Q1. A strong guidance instills investors' optimism.
McKesson (MCK) Beats on Q1 Earnings, Reiterates '19 View
by Zacks Equity Research
Strong prospects in Medical-Surgical business drove McKesson's (MCK) Q1. However, the company witnesses solid regulatory hurdles in the McKesson Canada business.
Varian Medical (VAR) Beats Q3 Earnings & Revenue Estimates
by Zacks Equity Research
Varian Medical (VAR) see strong growth in Oncology Systems. Solid guidance boosts investors' optimism.
Get Sweet Surprise on Earnings From 5 Top-Ranked Stocks
by Sanghamitra Saha
These top-ranked stocks are likely to beat on the bottom line in their next releases.
Here's Why You Should Hold Wright Medical (WMGI) Stock Now
by Zacks Equity Research
Here we take a quick look at the major factors that have been plaguing Wright Medical and discuss the prospects that ensure near-term recovery.
What's in Store for AngioDynamics (ANGO) in Q4 Earnings?
by Zacks Equity Research
AngioDynamics' (ANGO) expanding product pipeline, international market expansion and cost-saving initiatives to provide growth opportunities in Q4.
Wright Medical Gets FDA PMA for AUGMENT Injectable, Shares Up
by Zacks Equity Research
Wright Medical's (WMGI) AUGMENT Injectable Bone Graft platform has same clinical indications as the company's flagship AUGMENT Bone Graft.
Why is Wright Medical (WMGI) Up 18.8% Since Its Last Earnings Report?
by Zacks Equity Research
Wright Medical (WMGI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Wright Medical (WMGI) Beats on Q1 Earnings, Keeps Guidance
by Zacks Equity Research
Wright Medical's (WMGI) Q1 results solid; growth in upper and lower extremities segments encourages.
Why Is Wright Medical (WMGI) Down 4.7% Since Its Last Earnings Report?
by Zacks Equity Research
Wright Medical (WMGI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Wright Medical Expands Product Index for Advanced Diagnosis
by Zacks Equity Research
Wright Medical (WMGI) introduces new products that are likely to augment its lower extremities and biologics business.
Wright Medical (WMGI) Poised on Acquisitions Amid Forex Woes
by Zacks Equity Research
Wright Medical (WMGI) is focusing on product innovation through research and development. Also, the company is focusing on strategic acquisition and divestitures.
Wright Medical (WMGI) Beats Q4 Earnings & Revenue Estimates
by Zacks Equity Research
Wright Medical (WMGI) delivers promising Q4 results on the back of strength in its flagship Upper Extremities segment, despite declining international revenues of the Lower Extremities.
5 Reasons Why You Should Offload Wright Medical Stock Now
by Zacks Equity Research
Foreign currency fluctuations and pricing pressure continue to be major headwinds for Wright Medical Group (WMGI).
Wright Medical Upbeat on Preliminary Q4 & 2017 Sales Results
by Zacks Equity Research
Wright Medical (WMGI) forecasts improved sales, despite a plunge in revenues generated from the lower extremities business in fourth-quarter fiscal 2017.
Wright Medical (WMGI) Acquires IMASCAP SAS for $88.8 Million
by Zacks Equity Research
Wright Medical's (WMGI) acquisition of IMASCAP SAS will strengthen Extremities business.
Wright Medical (WMGI) Rides on Strong Portfolio & Innovation
by Zacks Equity Research
Wright Medical (WMGI) is focused on product innovation through research and development. However, lackluster international performance of the lower extremities segment is a matter of concern.
Wright Medical (WMGI) Portfolio Solid, Lower Extremities Dull
by Zacks Equity Research
Wright Medical (WMGI) is focusing on product innovation through research and development. However, lackluster international performance of the Lower extremities segment is a matter of concern.
Wright Medical Group (WMGI) Q3 Earnings In Line, Sales Miss
by Zacks Equity Research
Wright Medical (WMGI) posted loss as estimated in the third quarter on lower-than-expected sales.
Why Is Wright Medical (WMGI) Up 9.2% Since the Last Earnings Report?
by Zacks Equity Research
Wright Medical (WMGI) reported earnings more than a month ago. What's next for the stock? We take a look at earnings estimates for some clues.
Wright Medical Group (WMGI) Q2 Loss Narrower than Expected
by Zacks Equity Research
Wright Medical Group N.V. (WMGI) posted narrower-than-expected loss on account of strong growth in the U.S.